NCT00171171View on ClinicalTrials.gov

A Study of Long-term Treatment With Deferasirox in Patients With Beta-thalassemia and Transfusional Hemosiderosis

PHASE3CompletedINTERVENTIONAL
Enrollment

252

Participants

Timeline

Start Date

May 31, 2004

Primary Completion Date

November 30, 2006

Conditions
Beta-ThalassemiaHemosiderosis
Interventions
DRUG

deferasirox

Trial Locations (5)

Unknown

Novartis Investigative Site, Cairo

Novartis Investigative Site, Muscat

Novartis Investigative Site, Riyadh

Novartis Investigative Site, Damascus

Riad El Solh 1107 2020

Ali Taher, Beirut

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY

NCT00171171 - A Study of Long-term Treatment With Deferasirox in Patients With Beta-thalassemia and Transfusional Hemosiderosis | Biotech Hunter | Biotech Hunter